Gambacciani M - Search Results

1

Hormone replacement therapy and prevention of chronic conditions.

Gambacciani M, Cagnacci A, Lello S. Gambacciani M, et al. Climacteric. 2019 Jun;22(3):303-306. doi: 10.1080/13697137.2018.1551347. Epub 2019 Jan 10. Climacteric. 2019. PMID: 30626218 Review.

2

Lack of any estrogenic effect of ipriflavone in postmenopausal women.

Melis GB, Paoletti AM, Cagnacci A, Bufalino L, Spinetti A, Gambacciani M, Fioretti P. Melis GB, et al. Among authors: gambacciani m. J Endocrinol Invest. 1992 Nov;15(10):755-61. doi: 10.1007/BF03347647. J Endocrinol Invest. 1992. PMID: 1491124 Clinical Trial.

3

Neuroendocrine and clinical effects of transdermal 17 beta-estradiol in postmenopausal women.

Cagnacci A, Melis GB, Soldani R, Paoletti AM, Gambacciani M, Spinetti A, Fioretti P. Cagnacci A, et al. Among authors: gambacciani m. Maturitas. 1991 Oct;13(4):283-96. doi: 10.1016/0378-5122(91)90237-k. Maturitas. 1991. PMID: 1775082 Clinical Trial.

4

Prevention of postmenopausal bone loss and endometrial responses during a two year prospective study with transdermal 17 beta-estradiol and oral medroxyprogesterone acetate.

Fioretti P, Gambacciani M, Spinetti A, Cagnacci A, Paoletti AM, Felipetto R, Melis GB. Fioretti P, et al. Among authors: gambacciani m. Ann N Y Acad Sci. 1991;622:302-6. doi: 10.1111/j.1749-6632.1991.tb37875.x. Ann N Y Acad Sci. 1991. PMID: 1829595 No abstract available.

5

Influence of oestradiol and progesterone on pulsatile LH secretion in postmenopausal women.

Cagnacci A, Melis GB, Paoletti AM, Gambacciani M, Soldani R, Spinetti A, Fioretti P. Cagnacci A, et al. Among authors: gambacciani m. Clin Endocrinol (Oxf). 1989 Nov;31(5):541-50. doi: 10.1111/j.1365-2265.1989.tb01278.x. Clin Endocrinol (Oxf). 1989. PMID: 2516785

6

Effects of the antidopaminergic drug veralipride on LH and PRL secretion in postmenopausal women.

Fioretti P, Cagnacci A, Paoletti AM, Gambacciani M, Soldani R, Mauro GA, Spinetti A, Melis GB. Fioretti P, et al. Among authors: gambacciani m. J Endocrinol Invest. 1989 May;12(5):295-301. doi: 10.1007/BF03349989. J Endocrinol Invest. 1989. PMID: 2549113

7

Regulation of body temperature in postmenopausal women: interactions between bromocriptine and the endogenous opioid system.

Cagnacci A, Melis GB, Soldani R, Gambacciani M, Paoletti AM, Fioretti P. Cagnacci A, et al. Among authors: gambacciani m. Life Sci. 1989;44(19):1395-402. doi: 10.1016/0024-3205(89)90397-4. Life Sci. 1989. PMID: 2716477 Clinical Trial.

8

Chronic bromocriptine administration restores luteinizing hormone response to naloxone in postmenopausal women.

Melis GB, Cagnacci A, Gambacciani M, Paoletti AM, Caffi T, Fioretti P. Melis GB, et al. Among authors: gambacciani m. Neuroendocrinology. 1988 Feb;47(2):159-63. doi: 10.1159/000124907. Neuroendocrinology. 1988. PMID: 2830551

9

Restoration of luteinizing hormone response to naloxone in postmenopausal women by chronic administration of the antidopaminergic drug veralipride.

Melis GB, Cagnacci A, Gambacciani M, Paoletti AM, Moggi L, Fioretti P. Melis GB, et al. Among authors: gambacciani m. J Clin Endocrinol Metab. 1988 May;66(5):964-7. doi: 10.1210/jcem-66-5-964. J Clin Endocrinol Metab. 1988. PMID: 2834413

10

Sex steroids modulate prolactin response to naloxone in postmenopausal women.

Melis GB, Gambacciani M, Paoletti AM, Mais V, Cagnacci A, Petacchi FD, Fioretti P. Melis GB, et al. Among authors: gambacciani m. Neuroendocrinology. 1985 Aug;41(2):138-41. doi: 10.1159/000124167. Neuroendocrinology. 1985. PMID: 2995857

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

209 results

Search Page

Filters